Nymox Reports 78 Month Results From Biopsy And Surgery Confirmed Prospective Randomized NX03-0040 Prostate Cancer Study Of Fexapotide Triflutate: Gleason Grade Progression Reduced By 81% Overall
Benzinga_Newsdesk